DexCom, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2521311074
USD
69.97
0.08 (0.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,209.30
1,157.10
1,036.00
1,113.50
994.20
1,004.30
921.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,209.30
1,157.10
1,036.00
1,113.50
994.20
1,004.30
921.00
Raw Material Cost
461.90
468.30
447.00
457.70
400.40
377.60
359.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.70
4.70
4.70
4.90
4.70
4.80
4.60
Selling and Distribution Expenses
331.40
328.00
310.10
327.40
306.40
332.70
319.30
Other Expenses
15.28
14.35
14.05
13.46
13.07
13.12
13.69
Total Expenditure (Excl Depreciation)
950.80
944.50
902.30
924.60
842.20
846.30
819.90
Operating Profit (PBDIT) excl Other Income
258.5
212.60000000000002
133.7
188.9
152
158
101.1
Other Income
114.50
33.20
25.30
27.30
30.10
34.60
36.00
Operating Profit (PBDIT)
420.60
308.80
219.00
274.00
237.40
244.70
189.60
Interest
4.70
4.70
4.70
4.90
4.70
4.80
4.60
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
747.40
688.80
589.00
655.80
593.80
626.70
561.90
Depreciation
63.60
63.00
60.00
57.80
55.30
52.10
52.50
Profit Before Tax
352.30
241.10
154.30
211.30
177.40
187.80
132.50
Tax
68.50
61.30
48.90
59.60
42.80
44.30
-13.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
283.80
179.80
105.40
151.70
134.60
143.50
146.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
283.80
179.80
105.40
151.70
134.60
143.50
146.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
283.80
179.80
105.40
151.70
134.60
143.50
146.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,726.10
2,573.10
2,266.60
2,102.60
1,979.00
2,434.30
2,246.80
Earnings per share (EPS)
0.7
0.45
0.27
0.38
0.34
0.35
0.36
Diluted Earnings per share
0.7
0.45
0.27
0.38
0.34
0.35
0.36
Operating Profit Margin (Excl OI)
20.05%
18.37%
12.91%
16.96%
15.29%
15.73%
10.98%
Gross Profit Margin
34.39%
26.28%
20.69%
24.17%
23.41%
23.89%
20.09%
PAT Margin
23.47%
15.54%
10.17%
13.62%
13.54%
14.29%
15.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 21.64% vs 1.97% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 110.85% vs 11.52% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 47.66% vs -18.29% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 0.00% vs -4.08% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of DexCom, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,209.30
1,532.20
-322.90
-21.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,209.30
1,532.20
-322.90
-21.07%
Raw Material Cost
461.90
355.30
106.60
30.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.70
0.00
4.70
Selling and Distribution Expenses
331.40
502.00
-170.60
-33.98%
Other Expenses
15.28
27.62
-12.34
-44.68%
Total Expenditure (Excl Depreciation)
950.80
1,133.50
-182.70
-16.12%
Operating Profit (PBDIT) excl Other Income
258.50
398.70
-140.20
-35.16%
Other Income
114.50
40.20
74.30
184.83%
Operating Profit (PBDIT)
420.60
498.30
-77.70
-15.59%
Interest
4.70
0.00
4.70
Exceptional Items
0.00
-60.00
60.00
100.00%
Gross Profit (PBDT)
747.40
1,176.90
-429.50
-36.49%
Depreciation
63.60
38.10
25.50
66.93%
Profit Before Tax
352.30
400.20
-47.90
-11.97%
Tax
68.50
64.30
4.20
6.53%
Provisions and contingencies
0
0
0.00
Profit After Tax
283.80
337.60
-53.80
-15.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
283.80
337.60
-53.80
-15.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-1.70
1.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
283.80
335.90
-52.10
-15.51%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
2,726.10
10,545.30
-7,819.20
-74.15%
Earnings per share (EPS)
0.70
0.57
0.13
22.81%
Diluted Earnings per share
0.70
0.57
0.13
22.81%
Operating Profit Margin (Excl OI)
20.05%
27.41%
0.00
-7.36%
Gross Profit Margin
34.39%
28.61%
0.00
5.78%
PAT Margin
23.47%
22.03%
0.00
1.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 120.93 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.51% vs 11.69% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 21.64% vs 1.97% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 28.38 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 57.84% vs 70.59% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 110.85% vs 11.52% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.61 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 11.07% vs 42.28% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 47.66% vs -18.29% in Sep 2024

Quarterly - Interest
Interest 0.47 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs -4.08% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.05%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024